Big Gain For ImmunoGen, Inc.
Wed, May 03, 2023 at 07:26 PM
ImmunoGen, Inc. (IMGN:NASDAQ) jumped higher at $12.26, a gain of 135.8%. On Wed, May 03, 2023, IMGN:NASDAQ touched a New 2-Week High of $12.26. The stock got featured on our News Catalysts scanner on Wed, May 03, 2023 at 07:14 PM in the 'BIOTECH' category. From Wed, Apr 19, 2023, the stock recorded 70.00% Up Days and 72.73% Green Days
About ImmunoGen, Inc. (IMGN:NASDAQ)
Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.
Top 10 Gainers:
- ImmunoGen, Inc. (IMGN:NASDAQ), 135.77%
- Aptorum Group Limited (APM:NASDAQ), 104.64%
- Harbor Custom Development Inc. (HCDI:NASDAQ), 90.25%
- Aceragen Inc Com (ACGN:NASDAQ), 84.02%
- GD Culture Group Ltd Com (New) (GDC:NASDAQ), 69.71%
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 59.97%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 56.1%
- Sentage Holdings Inc. (SNTG:NASDAQ), 55.51%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 47.3%
- Akili Inc. (AKLI:NASDAQ), 46.79%